Search Results - "Fournier, Pierrick G.J."
-
1
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
Published in Cancer cell (08-06-2015)“…Transforming growth factor-β (TGF-β) regulates the expression of genes supporting breast cancer cells in bone, but little is known about prostate cancer bone…”
Get full text
Journal Article -
2
Molecular Biology of Bone Metastasis
Published in Molecular cancer therapeutics (01-10-2007)“…Metastasis is a final stage of tumor progression. Breast and prostate cancer cells preferentially metastasize to bone, wherein they cause incurable osteolytic…”
Get full text
Journal Article -
3
Bisphosphonates and cancer-induced bone disease : Beyond their antiresorptive activity
Published in Cancer research (Chicago, Ill.) (15-06-2005)“…Bisphosphonates are primarily known for their ability to inhibit osteoclast-mediated bone resorption. They are an indispensable part of therapy for patients…”
Get full text
Journal Article -
4
Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo
Published in Cancer research (Chicago, Ill.) (01-11-2008)“…Bisphosphonates bind avidly to bone mineral and are potent inhibitors of osteoclast-mediated bone destruction. They also exhibit antitumor activity in vitro…”
Get full text
Journal Article -
5
TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Published in Cancer research (Chicago, Ill.) (01-01-2011)“…Melanoma often metastasizes to bone where it is exposed to high concentrations of TGF-β. Constitutive Smad signaling occurs in human melanoma. Because TGF-β…”
Get full text
Journal Article -
6
Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
Published in Journal of bone and mineral research (01-08-2022)“…ABSTRACT Immunotherapies use components of the immune system, such as T cells, to fight cancer cells, and are changing cancer treatment, causing durable…”
Get full text
Journal Article -
7
Abstract 5812: Development of αVβ5 + exosomes for liver-targeted therapy
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Liver metastases are common in pancreatic and colorectal cancer. Their development is promoted by tumor-secreted exosomes that, thanks to the presence of the…”
Get full text
Journal Article -
8
Abstract 5281: 5-Fluorouracil decreases MDSC and the development of osteolytic bone metastases from breast cancer in mice
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Bone metastases are a highly debilitating complication in more than 70% of patients with advanced breast and prostate cancer. Currently approved treatments…”
Get full text
Journal Article -
9
Contribution of Macrophages and T Cells in Skeletal Metastasis
Published in Cancers (20-04-2020)“…Bone is a common site for metastases with a local microenvironment that is highly conducive for tumor establishment and growth. The bone marrow is replete with…”
Get full text
Journal Article -
10
Abstract 4147: Chitosan luminescent rare-earth doped nanoparticles as cancer cell tracking for imaging tumors and their immune response
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Background: Cancer is a group of diseases characterized by the unregulated growth of cells, which can be hard to diagnose due to the high false negatives or…”
Get full text
Journal Article -
11
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment
Published in PloS one (03-09-2009)“…Most patients with advanced breast cancer develop bone metastases, which cause pain, hypercalcemia, fractures, nerve compression and paralysis. Chemotherapy…”
Get full text
Journal Article -
12
Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
Published in Oncotarget (17-10-2017)“…More efficient therapies that target multiple molecular mechanisms are needed for the treatment of incurable bone metastases. Halofuginone is a plant…”
Get full text
Journal Article -
13
Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy
Published in Journal of nanobiotechnology (27-02-2018)“…Photodynamic therapy is a promising cancer therapy modality but its application for deep-seated tumor is mainly hindered by the shallow penetration of visible…”
Get full text
Journal Article -
14
Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging
Published in Journal of nanobiotechnology (22-03-2018)“…Breast cancer is the second leading cause of cancer death among women and represents 14% of death in women around the world. The standard diagnosis method for…”
Get full text
Journal Article -
15
Halofuginone Inhibits the Establishment and Progression of Melanoma Bone Metastases
Published in Cancer research (Chicago, Ill.) (01-12-2012)“…TGF-β derived from bone fuels melanoma bone metastases by inducing tumor secretion of prometastatic factors that act on bone cells to change the skeletal…”
Get full text
Journal Article -
16
The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm
Published in Oncotarget (18-04-2017)“…Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D…”
Get full text
Journal Article -
17
TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases
Published in Cancers (03-04-2020)“…Breast cancer (BCa) cells disseminating to the bone can remain dormant and resistant to treatments for many years until relapsing as bone metastases. The…”
Get full text
Journal Article -
18
Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity
Published in ImmunoHorizons (01-12-2022)“…Owing to ease of access and high yield, most murine myeloid-derived suppressor cell (MDSC) knowledge comes from the study of spleen-derived MDSCs rather than…”
Get full text
Journal Article -
19
In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization
Published in Oncotarget (15-06-2018)“…The stability, binding, and tissue penetration of variable new-antigen receptor (VNAR) single-domain antibodies have been tested as part of an investigation…”
Get full text
Journal Article -
20
BMP7: A New B one M etastases P revention?
Published in The American journal of pathology (2007)Get full text
Journal Article